Volume 93, Issue S255
ABS15-0165
Free Access

Fundus autofluorescence imaging in Toxic Retinopathies and in Gravitational descending atrophic retinal pigmented epithelial tracks

A. Cahuzac

A. Cahuzac

Fondation Ophtalmologique Rothschild, Service Pr Sahel, Paris, France

Search for more papers by this author
B. Wolff

B. Wolff

Fondation Ophtalmologique Rothschild, Service Pr Sahel, Paris, France

Search for more papers by this author
M. Lehmann

M. Lehmann

Ophtalmologie, Hotel Dieu, Paris, France

Search for more papers by this author
C. Scemama

C. Scemama

Fondation Ophtalmologique Rothschild, Service Pr Sahel, Paris, France

Search for more papers by this author
M. Mauget-Faÿsse

M. Mauget-Faÿsse

Fondation Ophtalmologique Rothschild, Service Pr Sahel, Paris, France

Search for more papers by this author
First published: 23 September 2015

Summary

Fundus autofluorescence (FAF) was studied in toxic retinopathy due to synthetic antimalarial drugs (SAM). It was not a screening tool, however it was useful for non-invasive follow up once retinal toxicity is established.

FAF was also studied in Central serous chorioretinopathy (CSC) and diffuse retinal pigment epitheliopathy (DRPE) where it showed abnormalities at both acute and late stage as well as gravitational descending atrophic retinal pigment epithelial tracks, with different caracteristics depending on the acute or chronic stage of the disease.

FAF was also studied in choroidal hemangioma where it showed various pattern of atrophic retinal pigment epithelial tracks, in chronic retinal detachment (RD) and in post-traumatic retinal lesions.

Fundus autofluorescence is a major non-invasive tool to monitor damaged retinal epithelium areas in various pathologies such as toxic retinopathy, CSC, DRPE, chroidal hemangioma and chronic retinal detachment.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.